Kei Muro, MD, Aichi Cancer Center Hospital
Advertisement
Articles by Kei Muro, MD, Aichi Cancer Center Hospital
Advertisement
Latest Updated Articles
Global Use of Frontline Therapy in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Perioperative Strategies in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Is Frontline IO Therapy Appropriate in Gastric Cancer?Published: June 2nd 2020 | Updated:
Metastatic Gastric Cancer: Identifying Disease ProgressionPublished: June 2nd 2020 | Updated:
Emerging Biomarkers in Metastatic Gastric CancerPublished: June 2nd 2020 | Updated:
Switch Maintenance in Gastric Cancer: Results of JAVELIN Gastric 100Published: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5